Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,637 | 41,958 | 56,718 | 25,031 | 55,061 |
| Marketable Securities | 27,798 | 26,943 | 27,999 | 19,854 | 22,167 |
| Receivables | N/A | N/A | 108 | 84 | 186 |
| Other current assets | 611 | 439 | 437 | 216 | 308 |
| TOTAL | $149,151 | $79,031 | $93,318 | $50,864 | $86,873 |
| Non-Current Assets | |||||
| PPE Net | 282 | 251 | 248 | 328 | 47 |
| Investments And Advances | 0 | 0 | 0 | 0 | 25,003 |
| Intangibles | 799 | 799 | 799 | 799 | 799 |
| Other Non-Current Assets | 12,782 | 3,535 | 3,016 | 2,790 | 750 |
| TOTAL | $13,863 | $4,585 | $4,063 | $3,917 | $26,600 |
| Total Assets | $163,014 | $83,616 | $97,381 | $54,782 | $113,473 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 30,041 | 36,377 | 25,877 | 15,268 | 9,346 |
| Accrued Expenses | 3,798 | 2,258 | 1,800 | 1,390 | 819 |
| Other current liabilities | 48,994 | 219 | N/A | N/A | N/A |
| TOTAL | $84,449 | $38,854 | $27,957 | $16,878 | $10,529 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,970 | N/A | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | 152 | 152 | 152 |
| Other Non-Current Liabilities | 10,218 | 18,350 | 0 | 0 | 0 |
| TOTAL | $39,950 | $20,726 | $2,431 | $2,035 | $1,371 |
| Total Liabilities | $124,399 | $59,580 | $30,388 | $18,914 | $11,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 109,401 | 83,871 | 75,580 | 56,909 | 54,095 |
| Common Shares | 109 | 84 | 73 | 57 | 54 |
| Retained earnings | -701,216 | -528,345 | -354,863 | -236,387 | -158,134 |
| Other shareholders' equity | -234 | -234 | -234 | -234 | -234 |
| TOTAL | $38,615 | $24,036 | $66,993 | $35,868 | $101,573 |
| Total Liabilities And Equity | $163,014 | $83,616 | $97,381 | $54,782 | $113,473 |